Background and Purpose-Global cerebral edema is common among patients with poor-grade subarachnoid hemorrhage and is associated with poor outcome. Currently no targeted therapy exists largely due to an incomplete understanding of the underlying mechanisms. Methods-This is a prospective observational study including 39 consecutive patients with poor-grade subarachnoid hemorrhage with multimodal neuromonitoring. Levels of microdialysate lactate-pyruvate ratio, episodes of cerebral metabolic crisis (lactate-pyruvate ratio Ͼ40 and brain glucose Ͻ0.7 mmol/L), brain tissue oxygen tension, cerebral perfusion pressure, and transcranial Doppler sonography flow velocities were analyzed. Results-Median age was 54 years (range, 45 to 61 years) and 62% were female. Patients with global cerebral edema on admission (nϭ24 [62%]) had a higher incidence of metabolic crisis in the first 12 hours of monitoring (nϭ15 [15% versus 2%], PϽ0.05) and during the total time of neuromonitoring (20% versus 3%, PϽ0.001) when compared to those without global cerebral edema. There was no difference in brain tissue oxygen tension or cerebral perfusion pressure between the groups; however, in patients with global cerebral edema, a higher cerebral perfusion pressure was associated with lower lactate-pyruvate ratio (PϽ0.05). Episodes of metabolic crisis were associated with poor outcome (modified Rankin Scale score 5 or 6, PϽ0.05). Conclusions-In patients with poor-grade subarachnoid hemorrhage, global cerebral edema is associated with early brain metabolic distress. (Stroke. 2011;42:00-00.)
G lobal cerebral edema is common after aneurysmal subarachnoid hemorrhage (SAH) and significantly impacts outcome. 1 Pathophysiological mechanisms are incompletely understood. The initial bleeding is associated with a rapid increase in intracranial pressure (ICP) and reduction in cerebral blood flow 2,3 leading to decreased substrate delivery to the brain during a time of increased demand. Animal data suggest that rising intracellular Caϩ, excitotoxicity, and mitochondrial dysfunction may contribute to cellular distress resulting in cytotoxic brain edema. 4 Currently available animal models, however, do not convincingly replicate the pathophysiology occurring in the setting of spontaneous aneurysmal SAH in humans. This is why human physiological data may be central to better understand mechanisms seen early after SAH. Invasive brain monitoring can assess brain metabolism and indicate brain tissue in metabolic distress based on energy supply deficiency (glucose, oxygen), mitochondrial dysfunction, or increased cellular demand hours before the irreversible damage occurs. 5, 6 Recently, global cerebral edema (GCE) after SAH was associated with increased cerebral energy metabolism indicated by increased cerebral extracellular levels of lactate and pyruvate. 7 There was no association with GCE and lactate-pyruvate ratio (LPR) and data on cerebral perfusion and brain tissue oxygenation (PbtO2) are not reported. 7 We examine patterns in brain metabolism in combination with PbtO2 and cerebral perfusion in patients with GCE after SAH. We tested the hypothesis that GCE is associated with cerebral metabolic distress in the setting of brain hypoperfusion.
Materials and Methods

Patients
Between June 2006 and December 2008, 39 patients with poor-grade SAH admitted to the neurological intensive care unit at Columbia University Medical Center underwent brain multimodality monitoring according to our institutional protocol. Data were collected as part of an ongoing prospective database approved by the local Institutional Review Board.
Global Cerebral Edema
GCE was diagnosed by senior researchers (J.C., N.B., K.L., S.A.M.) based on the initial cerebral CT scan as previously described: (1) complete or near-complete effacement of the hemispheric sulci and basal cisterns; and (2) bilateral and extensive disruption of the hemispheric gray-white matter junction at the level of the centrum semiovale, which was due to either blurring or diffuse peripheral "finger-like" extension of the normal demarcation between gray and white matter. 1
General Management
Patient care for SAH conformed to guidelines. 8 Hemodynamic and fluid management was targeted to maintain cerebral perfusion pressure (CPP) Ͼ60 mm Hg and ICP Ͻ20 mm Hg. 9
Intracranial Monitoring
At the time monitoring was started, all patients had a Glasgow Coma Scale (GCS) Յ8. Multimodality monitoring was initiated if (1) it was unlikely that the patient gains consciousness within the following 48 hours; and (2) the patient had a high probability to survive for the next 48 hours. This decision was made by the attending neurointensive care unit physician and head neurosurgeon. Through a burr hole, a triple-lumen bolt was affixed with a frontal approach (in patients who underwent aneurysm clipping contralateral to craniotomy [nϭ22; 56%]; after endovascular treatment in the nondominant frontal lobe in diffuse SAH or ipsilateral in lateralized SAH). A CMA-70 microdialysis catheter (CMA/Microdialysis, Stockholm, Sweden) was inserted into the brain parenchyma and hourly samples were analyzed (CMA-600; CMA/Microdialysis). At least 1 hour passed after the insertion of the probe and the start of the sampling to allow for normalization of changes due to probe insertion. PbtO2 was measured with a Licox Clark-type probe (Licox GMBHTM, Kiel-Germany; Integra Neurosciences, Plainsborough, NJ). ICP monitoring was performed using a parenchymal probe (Integra Neurosciences). The location of the monitoring catheters in the white matter was confirmed by brain CT scan immediately after the procedure. Metabolic crisis (MC) was defined as a microdialysate glucose Ͻ0.7 mmol/L together with LPR Ͼ40. 10, 11 
Statistical Analysis
Microdialysis, PbtO2, and cerebral perfusion measurements were averaged daily and time-locked to the onset of SAH. Group comparisons were performed using Mann-Whitney U (Bonferronicorrected), Student t test, 2 , and Fisher exact tests as appropriate. The percentage of hours spent in metabolic distress (LPR Ͼ40) and MC over the entire neuromonitoring time was calculated for every patient. Data are expressed as meanϮSD or median (interquartile range) unless otherwise indicated. Multivariable general linear models were calculated to determine the relationship over time of GCE to cerebral metabolism, PbtO2, and cerebral perfusion. Multiple observations per subject were handled by using generalized estimating equations with an autoregressive working correlation matrix. Continuous variables that were not normally distributed were normalized using logarithmic transformations. All statistical comparisons were done using SPSS 18 (SPSS Inc, Chicago, IL). Differences were considered significant at PϽ0.05.
Results
Patient Characteristics and Clinical Course
Patient baseline characteristics are given in the Table. A total of 3402 microdialysate samples from 39 patients with SAH were analyzed. Admission Glasgow Coma Scale was not different between groups (Pϭ0.2). All of the 9 patients with admission Hunt & Hess grades 1 to 3 deteriorated during hospitalization to a Hunt & Hess grade of 4 or 5 due to hydrocephalus, rebleeding, and cerebral ischemia (3 patients each). Patients with GCE (nϭ24 [62%]) were younger (49Ϯ13 versus 61Ϯ14 years, PϽ0.01), and all had reported loss of consciousness at ictus (versus 33%, PϽ0.001). Other admission variables and treatment choice (clipping versus coiling) did not differ between groups. Initial CT scanning revealed lateralized SAH in 12 patients equally distributed in both groups (GCE/ non-GCE: nϭ7/5 [29%/33%], Pϭ0.8). Insertion hematoma (Ͻ1 cm) was observed in 2 patients in the cortical area distant to the catheter tip. Median time to neuromonitoring was 2 days in both groups (Pϭ0.9). In-hospital complications did not differ significantly between groups (Table S1 ; http://stroke.ahajournals.org).
GCE and Brain Metabolism
In the first 12 hours of neuromonitoring, admission GCE was associated with lower brain pyruvate (102Ϯ48 mol/L versus 137Ϯ38 mol/L, PϽ0.05) and glucose levels (1.3Ϯ0.7 mmol/L versus 1.8Ϯ1.1 mmol/L, Pϭ0.07) resulting in a higher frequency of episodes of MC (15% versus 2%, PϽ0.05). During monitoring Days 2 and 10 after SAH, patients with GCE had a higher percentage of episodes in MC (20% versus 3%, PϽ0.001), of LPR Ͼ40 (42% versus 9%, Pϭ0.001; Figure 1 A), and a tendency to brain hypoglycemia (Ͻ0.7 mmol/L, 33% versus 18%, Pϭ0.1).
Daily Variations in Neuromonitoring Parameters in Patients With and Without GCE
Patients with GCE had higher overall LPR (PϽ0.05) and lower overall pyruvate levels (PϽ0.05). Brain glucose was higher in non-GCE patients during the first days of monitoring (PϽ0.01) and significantly decreased over time (PϽ0.001) to a nonsignificant difference by Day 7 ( Figure  1B -D). There was a trend toward higher ICP in patients with GCE (Pϭ0.05; Figure 2A) . No difference was observed in CPP, flow velocity in the middle cerebral artery ipsilateral to the neuromonitoring probes (not shown), PbtO2, or pressure reactivity index (PRx; Figure 2B -D). To verify the association between presence of GCE and elevated levels of LPR and decreased pyruvate levels, generalized estimating equation models were calculated with day post-SAH and presence of GCE as factors, including important covariates (gender, admission GCS). These models confirmed that LPR was higher and brain-pyruvate was lower early after SAH (SAH day significant at PϽ0.01, respectively) and in those with GCE (PϽ0.03 and Ͻ0.001, respectively). No significant interactions were identified ( Figure 1B ).
CPP and Brain Metabolism
To investigate a possible effect of CPP on brain metabolism in patients with and without GCE, 2 CPP groups were formed separated at the median (94 mm Hg). In patients with admission GCE, a higher CPP was associated with lower LPR (Figure 3 ); GEE analysis identified significant effects of high CPP (Pϭ0.003) and days post-SAH (Pϭ0.03) but not of their interaction (Pϭ0.06). CPP did not have an effect on LPR in patients without admission GCE (Pϭ0.6; graph not shown). There was no difference in ICP between these groups.
GCE and Metabolic Distress: Relationship With Outcome
Outcome at hospital discharge was assessed using modified Rankin Scale. 
Discussion
Our findings suggest that GCE after SAH is associated with brain metabolic distress. The present data are of potential importance because it is the first that allows a comprehensive assessment of brain metabolism, CPP, and brain oxygenation abnormalities seen in patients with GCE. Although a causative relationship cannot be proven using observational data alone, our findings may support blood flow augmentation in patients with GCE.
GCE is common in patients with poor-grade SAH and leads to a poor outcome. 1 Despite advances in monitoring techniques, pathophysiological mechanisms are incompletely understood. Rapid increase of ICP and brain circulatory arrest in the initial minutes after onset of SAH are followed by a lasting reduction of cerebral blood flow and may result in cytotoxic cerebral edema. 12, 13 The combination of substrate deficiency and cellular (mitochondrial) dysfunction results in brain metabolic distress indicated by markers of anaerobic metabolism. 6 Vasogenic edema may follow at the time when irreversible tissue damage and the breakdown of the bloodbrain barrier occur. 14 This irreversible neuronal cell loss occurs between the third and seventh days after bleeding, 15, 16 leaving a potential therapeutic window of 3 days after ictus. Therapeutic interventions restoring microcirculation after SAH in humans are limited. Raising mean arterial pressure targets can only be contemplated after clip or coil embolization of the aneurysm. Interventions should ideally start at an earlier time. Hypertonic solutions decrease brain water content and restore cerebral perfusion. Hypertonic saline is an effective osmotic agent with a high reflection coefficient at the blood-brain barrier resulting in brain shrinkage with ICP decrease. 17 In prehospital resuscitation of patients with trauma and severe traumatic brain injury, 18, 19 hypertonic saline has been proven beneficial most likely due to its osmotic potency. Mobilization of parenchymal and intraendothelial water restores intravascular volume and improves regional cerebral blood flow, 20 which enhances cerebral oxygen delivery in patients with traumatic brain injury and SAH with 21, 22 and without intracranial hypertension. 23 Increase in cardiac output, increase in oxygen delivery, and reduction of oxygen extraction were also observed when hypertonic solutions were infused over a time of approximately 20 minutes in severely brain-injured patients. 22 There are no trials of early brain resuscitation in patients with GCE after SAH; however, animal data suggest that early brain resuscitation with hypertonic saline improves neurological recovery and, when given in combination with dextran, exhibits survival benefit for neurons. 16, 24 Considering that the maximum brain water content is not seen until 24 hours and that morphological damage may not occur before 72 hours after ictus, 15 early initiation of a such a therapeutic intervention may be of benefit. In our series, higher CPP was associated with improved brain metabolism.
The median CPP in our patients was 92 mm Hg, which may be higher than in other intensive care units. Current guidelines recommend a CPP Ͼ60 mm Hg. 8 In general, blood pressure goals are liberalized after the aneurysm is secured. A European group investigating the effect of blood pressure variability on outcome report a median CPP Ͼ110 mm Hg in 105 patients with SAH. 25 Another driving factor for a high CPP is the occurrence of cerebral vasospasm. Bijlenga and colleagues reported an optimized CPP in this group of 98Ϯ4 mm Hg. 26 A high CPP may also reflect a physiological response in the setting of preserved cerebral autoregulation. In fact, PRx was lower in our patients with GCE, although not in the widely accepted range of preserved autoregulation. This has to be further investigated if a high CPP can serve as marker for severe injury in patients with SAH with GCE. We did not find a difference in PbtO2 in patients with and without GCE. PbtO2 is a measure of oxygen diffusion more than delivery. 27 Moreover, mitochondrial dysfunction may lead to failure in consumption of oxygen in patients with GCE and result in energy failure with increase in LPR despite normal PbtO2 values. 6 There was no difference in occurrence of fever, seizures, or ICP crisis between our groups; however, all of these complications may be associated with brain metabolic distress. Based on the present findings alone, we cannot provide information whether brain MC is a treatable condition in these patients. However, a valid approach would be to try to optimize and treat MC in an attempt to improve GCE.
Our results are not in the line with a recently published observational trial including 52 patients with SAH. 7 The authors observed a higher brain lactate and pyruvate but not LPR level in patients with admission GCE and interpreted their findings as cerebral hypermetabolism in the recovery phase after SAH. The most likely explanation is that our study included a group of more severe patients (19% World Federation of Neurological Surgeons V versus 33% Hunt & Hess 5 in our patients with GCE) supported by the higher LPR and lower interstitial glucose level in our patients with GCE. Additionally, only 64% of their patients had loss of consciousness in the GCE group compared with 100% in our study. Unfortunately, they did not report data on ICP, CPP, and hospital complications, which might have contributed to their findings. 7 A higher ICP may minimize energy delivery and increase the demand leading to anaerobic metabolism. Moreover, hypermetabolism may be a result of fever, seizures, or cerebral ischemia.
In this study, we did not measure local brain perfusion. Although CPP and mean transcranial Doppler velocities did not differ between groups, a subgroup analysis of patients with GCE suggested a metabolic benefit of increased CPP. Based on the assumption of autoregulatory failure in patients with GCE, a higher CPP may directly translate to better energy supply for brain tissue with secondary improvement of cerebral metabolism. This finding was not reproducible in non-GCE patients. Pressure reactivity index (PRx) was high in both groups (PRx, refer to reference 28). Our analysis of PRx has some methodological limitations. Taking the daily averaged data on PRx may not represent autoregulatory status appropriately. 29 We might have over-or underestimated PRx in each group. Moreover, this index is based on the correlation coefficient of ICP and mean arterial pressure and may therefore not properly represent local brain homeostasis.
Other potential weaknesses of this study deserve mention. The sample size is relatively small and no causative association between GCE and brain metabolism can be made based on observational data. These results are primarily hypothesisgenerating and should be considered as preliminary data. Secondarily, we did not monitor the first day after SAH. Metabolic changes may differ from the following monitoring days. Third, changes in brain and systemic variables cannot be attributed solely to GCE. To minimize this risk, we carefully tried to control for confounders. Fourth, inclusion criteria were based on the institutional criteria for multimodal neuromonitoring. This may have introduced a selection bias, although patients with GCE clinically rarely present without an altered level of consciousness and were therefore likely selected for neuromonitoring. On the other hand, critically ill patients not included in our monitoring based on early withdrawal of care might have aggravated the observed differences in brain metabolism.
Conclusions
In conclusion, our findings suggest that in patients with poor-grade SAH, GCE is associated with brain metabolic distress and increasing energy delivery to the brain may improve brain metabolism. Furthermore, investigations elucidating pathomechanisms underlying the development of GCE after SAH should combine animal models, advanced imaging, and invasive multimodality neuromonitoring techniques. Invasive neuromonitoring may verify findings from animal models such as the observation that the glial water channel protein aquaporin-4 is fundamental in the development of GCE in the mouse model of SAH. 30 Intervention trials studying the ability to modulate the development of GCE for example by activation or upregulation of aquaporin-4 could be powered to neuromonitoring or imaging end points. [17] 。在 创伤和严重创伤性脑损伤患者的院前复苏中 [18, 19] 血管内容量并改善局部脑血流量 [20] ，从而使伴 [21, 22] 和不伴 [23] 颅高压的创伤性脑损伤和 SAH 患者的脑 组织氧的输送得到提高。有研究也曾观察到严重脑 外伤患者经过大约 20 分钟的高张盐水输注后出现心 输出量增加、氧输送增加以及氧摄取减少 [22] 。还没 有关于 SAH 之后伴 GCE 患者早期脑复苏的临床试 验。然而，动物实验数据提示，早期高张盐水脑复 苏可促进神经功能恢复，而当与右旋糖酐合用时， 可提高神经元的存活率 [16, 24] 
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Supplemental Table S1
从入院至神经系统监测的天数 2(1-3) 神经系统监护的天数 6(4-9) 数值表达为均数 ( 标准差 )、中位数 ( 四分位数 ) 或例数 (%)。 SAH，蛛网膜下腔出血 ；IVH，脑室内出血。 图 1 伴 (■) 和不伴 (□) 全脑水肿 (GCE) 患 者蛛网膜下腔出血后第 2 至 10 天内代谢应 激 (LPR>40，A) 的 平 均 ( 标 准 误 ) 百 分 比 和乳酸 / 丙酮酸比值 (LPR，B)、丙酮酸 (C)、 脑葡萄糖 (D) 的日平均值 ( 标准误 ) 的差异。 监测期间 LPR>40 的小时 % 距起病天数 距起病天数 距起病天数 丙酮酸 (µmol/L) 葡萄糖 (mmol/L) P<0.001)。两组间入院时其他变量和治疗选择 ( 开颅 夹闭和血管内栓塞 ) 没有差异。首次 CT 扫描显示偏 侧 SAH 的 12 例患者在两组的分布相等 ( 有 GCE/ 无 GCE
